The outlook of companies tied to flagship drugs like Viagra presents a complex investment landscape . While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the expiry in key regions has introduced substantial uncertainty . Investors are now grappling with the consequences of rival medicatio